SCHEMBL383619

SCHEMBL383619

[CH]=CCC(C)CCCC(C)C

nearest known ligand 0.55

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.55
BLM P54132 1/20 0.40
PTPN1 P18031 3/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
KMT2A Q03164 1/20 0.39
PTPN2 P17706 1/20 0.30
CDC25B P30305 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL385932 0.98 LMNA (0.59) LMNABLMPTPN1MEN1CYP3A4
SCHEMBL386505 0.80
SCHEMBL2120409 0.78 OPRM1 (0.42) LMNA
SCHEMBL383797 0.78 LMNA (0.31) LMNA
SCHEMBL383875 0.78 LMNA (0.31) LMNA
SCHEMBL386591 0.78 LMNA (0.31) LMNA
SCHEMBL11517915 0.76 ACE2 (0.44) LMNA
SCHEMBL386581 0.76 LMNA (0.34) LMNA
SCHEMBL387540 0.76 LMNA (0.34) LMNA
SCHEMBL386571 0.76 LMNA (0.34) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150141502-A1 INHIBITION OF LEUKEMIC STEM CELLS BY PP2A ACTIVATING AGENTS Ohio State Innvation Foundation (US) 2015-05-21 US claimed
EP-2418948-B1 ANTIADHESION AGENTS UNIV OHIO STATE RES FOUND (US) 2013-09-04 EP claimed
US-8461362-B2 Protein phosphatase 2A-activating agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-06-11 US claimed
US-8362071-B2 Antiadhesion agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-01-29 US claimed
EP-2419414-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS The Ohio State University Research Foundation (US) 2012-02-22 EP claimed
EP-2418948-A1 ANTIADHESION AGENTS The Ohio State University Research Foundation (US) 2012-02-22 EP claimed
WO-2010121111-A9 ANTIADHESION AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-12-22 WO claimed
US-20100267820-A1 ANTIADHESION AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-10-21 US claimed
US-20100267673-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS THE OHIO SATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-10-21 US claimed
WO-2010121111-A1 ANTIADHESION AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-10-21 WO claimed
WO-2010120711-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2010-10-21 WO claimed
US-4125735-A Synthesis of esters of acetylenic alcohols SCM CORPORATION (US) 1978-11-14 US claimed
US-4115466-A ACETYLENIC HYDROCARBONS FROM ACETYLENIC CARBINOLS, ISOMERIZATION SCM CORPORATION (US) 1978-09-19 US claimed
US-9220706-B2 Inhibition of leukemic stem cells by PP2A activating agents NATIONAL INSTITUTES OF HEALTH (NIH) (US) 2015-12-29 US disclosed
US-9220706-B2 Inhibition of leukemic stem cells by PP2A activating agents NATIONAL INSTITUTES OF HEALTH (NIH) (US) 2015-12-29 US disclosed
US-20150141502-A1 INHIBITION OF LEUKEMIC STEM CELLS BY PP2A ACTIVATING AGENTS Ohio State Innvation Foundation (US) 2015-05-21 US disclosed
US-20030236297-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2003-12-25 US disclosed
EP-1300405-A1 AMINO ALCOHOL DERIVATIVES Sankyo Company, Limited (JP) 2003-04-09 EP disclosed
US-4125735-A Synthesis of esters of acetylenic alcohols SCM CORPORATION (US) 1978-11-14 US disclosed
US-4039591-A 1-ACETOXY-4-CHLORO-3-METHYLBUT-2-ENE SCM CORPORATION (US) 1977-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236297-A1 Amino alcohol derivatives CD4, ADH1C, ADH1A LMNA 3703/4885BLM 4551/4885PTPN1 2617/4885
US-20100267673-A1 PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS PPP2CA, PPP2R2A, PPP2R1A LMNA 3602/4885BLM 4530/4885PTPN1 386/4885
US-20150141502-A1 INHIBITION OF LEUKEMIC STEM CELLS BY PP2A ACTIVATING AGENTS PPM1A, PPM1G, PPM1F LMNA 3971/4885BLM 4068/4885PTPN1 38/4885
US-20100267820-A1 ANTIADHESION AGENTS SELE, EPCAM, SELP LMNA 2725/4885BLM 3727/4885PTPN1 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.